Randomized, double-blind, crossover study comparing DFN-11 injection (3 mg subcutaneous sumatriptan) with 6 mg subcutaneous sumatriptan for the treatment of rapidly-escalating attacks of episodic migraine

BACKGROUND: A 6-mg dose of SC sumatriptan is the most efficacious and fast-acting acute treatment for migraine, but a 3-mg dose of SC sumatriptan may improve tolerability while maintaining efficacy. METHODS: This randomized, double-blind, crossover study compared the efficacy and tolerability of 3 m...

Descripción completa

Detalles Bibliográficos
Autores principales: Cady, Roger K., Munjal, Sagar, Cady, Ryan J., Manley, Heather R., Brand-Schieber, Elimor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5296269/
https://www.ncbi.nlm.nih.gov/pubmed/28176235
http://dx.doi.org/10.1186/s10194-016-0717-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5296269/
https://www.ncbi.nlm.nih.gov/pubmed/28176235
http://dx.doi.org/10.1186/s10194-016-0717-7

Ejemplares similares